Medclair AB (NGM: MCLR)
Sweden
· Delayed Price · Currency is SEK 1.320
0.00 (0.00%)
At close: Nov 19, 2024
Medclair AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | 50.3 | 42.42 | 28.17 | 13.32 | 6.41 | 5.81 | Upgrade
|
| Revenue Growth (YoY) | 53.43% | 50.60% | 111.49% | 107.70% | 10.30% | 9.80% | Upgrade
|
| Cost of Revenue | 21.23 | 17.66 | 7.76 | 5.8 | 2.15 | 3.09 | Upgrade
|
| Gross Profit | 29.07 | 24.76 | 20.41 | 7.52 | 4.26 | 2.72 | Upgrade
|
| Selling, General & Admin | 26.13 | 21.91 | 19 | 15.32 | 5.36 | 5.08 | Upgrade
|
| Other Operating Expenses | 0.02 | 0 | - | -0.09 | -0.45 | 0 | Upgrade
|
| Operating Expenses | 31.78 | 27.44 | 24.38 | 20.34 | 5.95 | 6.16 | Upgrade
|
| Operating Income | -2.71 | -2.68 | -3.97 | -12.82 | -1.69 | -3.44 | Upgrade
|
| Interest Expense | -0.37 | -0.37 | -0.08 | -0.11 | -0.11 | -0.15 | Upgrade
|
| Interest & Investment Income | 5.53 | 0.2 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.83 | -0.83 | -0.37 | -0.09 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.08 | -0 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 1.55 | -3.67 | -4.42 | -13.01 | -1.81 | -3.59 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.9 | 0.9 | -0.57 | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | -0.2 | - | Upgrade
|
| Pretax Income | 2.44 | -2.78 | -4.99 | -13.01 | -2.01 | -3.59 | Upgrade
|
| Income Tax Expense | 0.01 | 0.01 | 0.01 | 0.01 | - | - | Upgrade
|
| Net Income | 2.43 | -2.79 | -5 | -13.02 | -2.01 | -3.59 | Upgrade
|
| Net Income to Common | 2.43 | -2.79 | -5 | -13.02 | -2.01 | -3.59 | Upgrade
|
| Shares Outstanding (Basic) | 95 | 93 | 83 | 81 | - | - | Upgrade
|
| Shares Outstanding (Diluted) | 95 | 93 | 83 | 81 | - | - | Upgrade
|
| Shares Change (YoY) | 29.08% | 11.40% | 2.41% | - | - | - | Upgrade
|
| EPS (Basic) | 0.03 | -0.03 | -0.06 | -0.16 | - | - | Upgrade
|
| EPS (Diluted) | 0.03 | -0.03 | -0.06 | -0.16 | - | - | Upgrade
|
| Free Cash Flow | 8.41 | 4.23 | -11.77 | -8.68 | 0.18 | - | Upgrade
|
| Free Cash Flow Per Share | 0.09 | 0.05 | -0.14 | -0.11 | - | - | Upgrade
|
| Gross Margin | 57.79% | 58.38% | 72.46% | 56.45% | 66.42% | 46.83% | Upgrade
|
| Operating Margin | -5.40% | -6.32% | -14.10% | -96.25% | -26.40% | -59.21% | Upgrade
|
| Profit Margin | 4.84% | -6.57% | -17.75% | -97.76% | -31.33% | -61.72% | Upgrade
|
| Free Cash Flow Margin | 16.72% | 9.97% | -41.79% | -65.16% | 2.73% | - | Upgrade
|
| EBITDA | 1.89 | 1.84 | 0.12 | -8.85 | -0.86 | -2.36 | Upgrade
|
| EBITDA Margin | 3.76% | 4.33% | 0.41% | -66.44% | -13.38% | -40.63% | Upgrade
|
| D&A For EBITDA | 4.61 | 4.52 | 4.09 | 3.97 | 0.84 | 1.08 | Upgrade
|
| EBIT | -2.71 | -2.68 | -3.97 | -12.82 | -1.69 | -3.44 | Upgrade
|
| EBIT Margin | -5.40% | -6.32% | -14.10% | -96.25% | -26.40% | -59.21% | Upgrade
|
| Revenue as Reported | 43.32 | 43.32 | 28.44 | 13.41 | 6.9 | 5.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.